clinicaltrials.gov
Feed RSS ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days
Dapatkan update terbaru dari ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days langsung begitu tersedia.
Postingan terbaru
Dapatkan ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days di tempat Anda membaca
Orang yang mengikuti ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days juga mengikuti
-
Amylyx Pharmaceuticals, Inc. SEC Filings investors.amylyx.com
-
Alzforum News alzforum.org
-
Search Feed scrip.pharmaintelligence.informa.com
-
-
Eli Lilly and Company SEC Filings investor.lilly.com
-
-
investors.pfizer.com investors.pfizer.com
-
AbbVie Events investors.abbvie.com
Lebih banyak feed RSS untuk dijelajahi
-
ClinicalTrials.gov: Gastric Cancer | Not yet recruiting, Recruiting, Active, not recruiting studies | Phase: 3 | Interventional studies | Funded by Industry | Last update posted in the last 14 days clinicaltrials.gov
-
-
Pertanyaan
Apa URL feed RSS untuk ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days?
Alamat feed-nya adalah https://clinicaltrials.gov/api/rss?cond=Alzheimer+Disease&intr=Lecanemab+OR+donanemab+OR+Remternetug+OR+Trontinemab+OR+Crenezumab+OR+Valitramiprostate&dateField=LastUpdatePostDate. Tempelkan ke pembaca RSS apa pun, atau klik Ikuti sekarang untuk membacanya di Feeder.
Seberapa sering ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days memposting?
ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days memposting sekitar 4 kali seminggu. Postingan terakhir diterbitkan 1 hari lalu.
Apakah feed RSS ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days berfungsi?
Ya. Feeder memeriksanya 1 menit lalu dan feed merespons secara normal.
Bagaimana cara mengikuti ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days di Feeder?
Klik Ikuti sekarang, lalu daftar jika Anda belum memiliki akun. Paket gratis Feeder mencakup hingga 200 feed, di web, iPhone, dan Android. Tidak memerlukan kartu kredit.
Ikuti ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days di Feeder
Paket gratis Feeder mencakup hingga 200 feed, di web, iPhone, dan Android. Tidak memerlukan kartu kredit.